Replies to post #346074 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

The science does suggest that it could be applicable to veterinary medicine in theory. But, it will need to be scientifically tested to confirm.

[hyperopia]

Yes, DCVax is applicable in veterinary medicine, but may not be profitable depending on manufacturing costs.

NW Bio is already using these next generation methods for producing more potent dendritic cells in its production of DCVax-Direct. The same patented methods for activating dendritic cells were also used in the pre-clinical animal studies with DCVax-Direct. In those studies, injection of these potent dendritic cells into some of the tumors in each of the animals resulted in complete clearance of all tumors (both the tumors injected with DCVax-Direct and the tumors not injected) in 80-100% of the animals in the various studies, indicating a system-wide immune response.

https://nwbio.com/nw-bio-receives-u-s-patent-on-broad-processes-for-producing-more-potent-dendritic-cells/